Table I. Baseline characteristics of patients treated with immune checkpoint inhibitors.
IMDC: International Metastatic Renal Cell Carcinoma Database Consortium; IQR: Interquartile Range; irAEs: immune-related adverse events; NLR: neutrophil-lymphocyte ratio; RCC: renal cell carcinoma. Statistically significant p-values are shown in bold.